NYSE:PBH - Prestige Consumer Healthcare Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $28.08 +0.43 (+1.56 %) (As of 04/19/2019 04:00 PM ET)Previous Close$28.08Today's Range$27.52 - $28.125052-Week Range$26.25 - $41.76Volume338,138 shsAverage Volume573,249 shsMarket Capitalization$1.45 billionP/E Ratio10.88Dividend YieldN/ABeta0.98 ProfileDiscussionAnalyst RatingsChartDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) healthcare and household cleaning products in North America, Australia, and internationally. It operates in three segments: North American OTC Healthcare, International OTC Healthcare, and Household Cleaning. The company's OTC healthcare products include BC/Goody's analgesic powders, Beano for gas prevention, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids/lozenges, Clear Eyes for eye allergy/redness relief, Compound W for wart removal, Debrox for ear wax removal, DenTek PEG oral care, Dramamine for motion sickness relief, and Efferdent denture cleanser tablets. Its OTC healthcare products portfolio also comprises Fess nasal saline spray, Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Hydralyte for oral rehydration, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Pedia-Lax pediatric laxatives, Summer's Eve for feminine hygiene, Little Remedies pediatric OTC products, and The Doctor's NightGuard dental protectors. In addition, the company offers household cleaning products, such as abrasive tub and tile cleaners under the Comet name, as well as Chore Boy, and Spic and Span names. It serves mass merchandisers; and drug, food, dollar, convenience, and club stores. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York. Receive PBH News and Ratings via Email Sign-up to receive the latest news and ratings for PBH and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry Pharmaceutical preparations Sub-IndustryPersonal Products SectorConsumer Discretionary Current SymbolNYSE:PBH Previous Symbol CUSIP74112D10 CIK1295947 Webwww.prestigebrands.com Phone914-524-6800Debt Debt-to-Equity Ratio1.49 Current Ratio2.28 Quick Ratio1.34Price-To-Earnings Trailing P/E Ratio10.88 Forward P/E Ratio10.14 P/E Growth1.6 Sales & Book Value Annual Sales$1.04 billion Price / Sales1.40 Cash Flow$3.3231 per share Price / Cash Flow8.45 Book Value$22.22 per share Price / Book1.26Profitability EPS (Most Recent Fiscal Year)$2.58 Net Income$339.57 million Net Margins6.44% Return on Equity11.85% Return on Assets3.79%Miscellaneous Employees530 Outstanding Shares51,798,000Market Cap$1.45 billion Next Earnings Date5/9/2019 (Confirmed) OptionableOptionable Prestige Consumer Healthcare (NYSE:PBH) Frequently Asked Questions What is Prestige Consumer Healthcare's stock symbol? Prestige Consumer Healthcare trades on the New York Stock Exchange (NYSE) under the ticker symbol "PBH." How were Prestige Consumer Healthcare's earnings last quarter? Prestige Consumer Healthcare Inc (NYSE:PBH) issued its earnings results on Thursday, February, 7th. The company reported $0.73 EPS for the quarter, beating the Zacks' consensus estimate of $0.71 by $0.02. The business earned $241.40 million during the quarter, compared to analysts' expectations of $241.40 million. Prestige Consumer Healthcare had a net margin of 6.44% and a return on equity of 11.85%. The company's quarterly revenue was down 10.8% compared to the same quarter last year. During the same period in the prior year, the business earned $0.70 earnings per share. View Prestige Consumer Healthcare's Earnings History. When is Prestige Consumer Healthcare's next earnings date? Prestige Consumer Healthcare is scheduled to release their next quarterly earnings announcement on Thursday, May 9th 2019. View Earnings Estimates for Prestige Consumer Healthcare. What guidance has Prestige Consumer Healthcare issued on next quarter's earnings? Prestige Consumer Healthcare issued an update on its FY19 earnings guidance on Thursday, February, 7th. The company provided earnings per share (EPS) guidance of $2.75-$2.78 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.76. The company issued revenue guidance of $970-$975 million, compared to the consensus revenue estimate of $971.99 million.Prestige Consumer Healthcare also updated its FY 2019 guidance to $2.75-2.78 EPS. What price target have analysts set for PBH? 5 brokerages have issued 12 month price objectives for Prestige Consumer Healthcare's stock. Their predictions range from $28.40 to $97.00. On average, they expect Prestige Consumer Healthcare's stock price to reach $57.88 in the next twelve months. This suggests a possible upside of 106.1% from the stock's current price. View Analyst Price Targets for Prestige Consumer Healthcare. What is the consensus analysts' recommendation for Prestige Consumer Healthcare? 5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Prestige Consumer Healthcare in the last year. There are currently 4 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Prestige Consumer Healthcare. Has Prestige Consumer Healthcare been receiving favorable news coverage? Media coverage about PBH stock has been trending positive recently, InfoTrie reports. The research group identifies negative and positive media coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Prestige Consumer Healthcare earned a news sentiment score of 2.6 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the company's share price in the next few days. Who are some of Prestige Consumer Healthcare's key competitors? Some companies that are related to Prestige Consumer Healthcare include Nektar Therapeutics (NKTR), Alkermes (ALKS), Patheon (PTHN), Array Biopharma (ARRY), GW Pharmaceuticals PLC- (GWPH), Horizon Pharma (HZNP), Ascendis Pharma A/S (ASND), United Therapeutics (UTHR), TESARO (TSRO), Taro Pharmaceutical Industries (TARO), HUTCHISON CHINA/S (HCM), FibroGen (FGEN), Evotec (EVTCY), Amneal Pharmaceuticals (AMRX) and ACADIA Pharmaceuticals (ACAD). What other stocks do shareholders of Prestige Consumer Healthcare own? Based on aggregate information from My MarketBeat watchlists, some companies that other Prestige Consumer Healthcare investors own include Micron Technology (MU), Gilead Sciences (GILD), GW Pharmaceuticals PLC- (GWPH), AbbVie (ABBV), Cara Therapeutics (CARA), Dropcar (DCAR), Rigel Pharmaceuticals (RIGL), Boeing (BA), Edwards Lifesciences (EW) and Merck & Co., Inc. (MRK). Who are Prestige Consumer Healthcare's key executives? Prestige Consumer Healthcare's management team includes the folowing people: Mr. Ronald M. Lombardi, Chairman, Pres & CEO (Age 55)Ms. Christine Sacco, Chief Financial Officer (Age 43)Mr. William C. P'Pool, Sr. VP, Gen. Counsel & Corp. Sec. (Age 54)Mr. Timothy J. Connors, Exec. VP of Sales & Marketing (Age 52)Mr. Jeff Zerillo, Sr. VP of Operations Who are Prestige Consumer Healthcare's major shareholders? Prestige Consumer Healthcare's stock is owned by many different of retail and institutional investors. Top institutional investors include Dalton Greiner Hartman Maher & Co. (0.74%), First Manhattan Co. (0.72%), Skyline Asset Management LP (0.64%), Retirement Systems of Alabama (0.41%), Tibra Equities Europe Ltd (0.04%) and Meeder Asset Management Inc. (0.04%). Company insiders that own Prestige Consumer Healthcare stock include Gary E Costley, Jean A Boyko, Natale S Ricciardi, Ronald M Lombardi, Timothy Connors and William P'pool. View Institutional Ownership Trends for Prestige Consumer Healthcare. Which major investors are selling Prestige Consumer Healthcare stock? PBH stock was sold by a variety of institutional investors in the last quarter, including Skyline Asset Management LP, First Manhattan Co. and Dalton Greiner Hartman Maher & Co.. Company insiders that have sold Prestige Consumer Healthcare company stock in the last year include Jean A Boyko and Timothy Connors. View Insider Buying and Selling for Prestige Consumer Healthcare. Which major investors are buying Prestige Consumer Healthcare stock? PBH stock was purchased by a variety of institutional investors in the last quarter, including Retirement Systems of Alabama, Tibra Equities Europe Ltd, Eqis Capital Management Inc., Meeder Asset Management Inc., First Citizens Bank & Trust Co. and Financial Gravity Wealth Inc.. Company insiders that have bought Prestige Consumer Healthcare stock in the last two years include Gary E Costley, Natale S Ricciardi, Ronald M Lombardi and William P'pool. View Insider Buying and Selling for Prestige Consumer Healthcare. How do I buy shares of Prestige Consumer Healthcare? Shares of PBH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Prestige Consumer Healthcare's stock price today? One share of PBH stock can currently be purchased for approximately $28.08. How big of a company is Prestige Consumer Healthcare? Prestige Consumer Healthcare has a market capitalization of $1.45 billion and generates $1.04 billion in revenue each year. The company earns $339.57 million in net income (profit) each year or $2.58 on an earnings per share basis. Prestige Consumer Healthcare employs 530 workers across the globe. What is Prestige Consumer Healthcare's official website? The official website for Prestige Consumer Healthcare is http://www.prestigebrands.com. How can I contact Prestige Consumer Healthcare? Prestige Consumer Healthcare's mailing address is 660 WHITE PLAINS ROAD SUITE 250, TARRYTOWN NY, 10591. The company can be reached via phone at 914-524-6800 or via email at [email protected] MarketBeat Community Rating for Prestige Consumer Healthcare (NYSE PBH)Community Ranking: 2.9 out of 5 ( )Outperform Votes: 387 (Vote Outperform)Underperform Votes: 284 (Vote Underperform)Total Votes: 671MarketBeat's community ratings are surveys of what our community members think about Prestige Consumer Healthcare and other stocks. Vote "Outperform" if you believe PBH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PBH will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 4/20/2019 by MarketBeat.com StaffFeatured Article: What is the downside to momentum investing?